MWNA
MIRM icon

Marshall Wace North America’s Mirum Pharmaceuticals MIRM Stock Holding History

Marshall Wace North America’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.06M Buy
+53,408
New +$869K ﹤0.01% 897
2020
Q1 		– Sell
-1,011
Closed -$25K – 1455
2019
Q4 		$25K Buy
+1,011
New +$10.8K ﹤0.01% 1195

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace North America's MIRM Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2021: 53,408 shares worth $1.06M. The stake represents ﹤0.01% of the portfolio and ranks #897 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in MIRM as recently as Q4 2019.

Marshall Wace North America first reported a position in MIRM in Q4 2019 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold MIRM as of Q3 2021.

  • Marshall Wace North America held 53,408 shares of Mirum Pharmaceuticals worth $1.06M as of Q3 2021.
  • Mirum Pharmaceuticals was a new Marshall Wace North America position in Q3 2021.
  • Mirum Pharmaceuticals made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #897 holding.
  • Marshall Wace North America first reported a position in Mirum Pharmaceuticals in Q4 2019 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.